Testing Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver Functions

Clinical trial NCT05622071 · COMPLETED

Trial details

NCT number: NCT05622071
Sponsor: UNICANCER
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma by BCLC Stage

Start date: 2023-10-12
Primary completion: 2025-06-15
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.